Cargando…

Holographic Quantitative Structure-Activity Relationships of Tryptamine Derivatives at NMDA, 5HT(1A) and 5HT(2A) Receptors

Tryptamine derivatives (Ts) were found to inhibit the binding of [(3)H]MK-801, [(3)H]ketanserin and [(3)H]8-OH-DPAT to rat brain membranes. [(3)H]MK-801 labels the NMDA (N-methyl-D-aspartate) receptor, a ionotropic glutamate receptor which controls synaptic plasticity and memory function in the brai...

Descripción completa

Detalles Bibliográficos
Autores principales: Palangsuntikul, Rungtiva, Berner, Heinz, Berger, Michael L., Wolschann, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270498/
https://www.ncbi.nlm.nih.gov/pubmed/23887721
http://dx.doi.org/10.3390/molecules18088799
_version_ 1783376713138307072
author Palangsuntikul, Rungtiva
Berner, Heinz
Berger, Michael L.
Wolschann, Peter
author_facet Palangsuntikul, Rungtiva
Berner, Heinz
Berger, Michael L.
Wolschann, Peter
author_sort Palangsuntikul, Rungtiva
collection PubMed
description Tryptamine derivatives (Ts) were found to inhibit the binding of [(3)H]MK-801, [(3)H]ketanserin and [(3)H]8-OH-DPAT to rat brain membranes. [(3)H]MK-801 labels the NMDA (N-methyl-D-aspartate) receptor, a ionotropic glutamate receptor which controls synaptic plasticity and memory function in the brain, whereas [(3)H]ketanserin and [(3)H]8-OH-DPAT label 5HT(2A) and 5HT(1A) receptors, respectively. The inhibitory potencies of 64 Ts (as given by IC(50) values) were correlated with their structural properties by using the Holographic QSAR procedure (HQSAR). This method uses structural fragments and connectivities as descriptors which were encoded in a hologram thus avoiding the usual problems with conformation and alignment of the structures. Four correlation equations with high predictive ability and appropriate statistical test values could be established. The results are visualized by generation of maps reflecting the contribution of individual structural parts to the biological activities.
format Online
Article
Text
id pubmed-6270498
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-62704982018-12-18 Holographic Quantitative Structure-Activity Relationships of Tryptamine Derivatives at NMDA, 5HT(1A) and 5HT(2A) Receptors Palangsuntikul, Rungtiva Berner, Heinz Berger, Michael L. Wolschann, Peter Molecules Article Tryptamine derivatives (Ts) were found to inhibit the binding of [(3)H]MK-801, [(3)H]ketanserin and [(3)H]8-OH-DPAT to rat brain membranes. [(3)H]MK-801 labels the NMDA (N-methyl-D-aspartate) receptor, a ionotropic glutamate receptor which controls synaptic plasticity and memory function in the brain, whereas [(3)H]ketanserin and [(3)H]8-OH-DPAT label 5HT(2A) and 5HT(1A) receptors, respectively. The inhibitory potencies of 64 Ts (as given by IC(50) values) were correlated with their structural properties by using the Holographic QSAR procedure (HQSAR). This method uses structural fragments and connectivities as descriptors which were encoded in a hologram thus avoiding the usual problems with conformation and alignment of the structures. Four correlation equations with high predictive ability and appropriate statistical test values could be established. The results are visualized by generation of maps reflecting the contribution of individual structural parts to the biological activities. MDPI 2013-07-24 /pmc/articles/PMC6270498/ /pubmed/23887721 http://dx.doi.org/10.3390/molecules18088799 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Palangsuntikul, Rungtiva
Berner, Heinz
Berger, Michael L.
Wolschann, Peter
Holographic Quantitative Structure-Activity Relationships of Tryptamine Derivatives at NMDA, 5HT(1A) and 5HT(2A) Receptors
title Holographic Quantitative Structure-Activity Relationships of Tryptamine Derivatives at NMDA, 5HT(1A) and 5HT(2A) Receptors
title_full Holographic Quantitative Structure-Activity Relationships of Tryptamine Derivatives at NMDA, 5HT(1A) and 5HT(2A) Receptors
title_fullStr Holographic Quantitative Structure-Activity Relationships of Tryptamine Derivatives at NMDA, 5HT(1A) and 5HT(2A) Receptors
title_full_unstemmed Holographic Quantitative Structure-Activity Relationships of Tryptamine Derivatives at NMDA, 5HT(1A) and 5HT(2A) Receptors
title_short Holographic Quantitative Structure-Activity Relationships of Tryptamine Derivatives at NMDA, 5HT(1A) and 5HT(2A) Receptors
title_sort holographic quantitative structure-activity relationships of tryptamine derivatives at nmda, 5ht(1a) and 5ht(2a) receptors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270498/
https://www.ncbi.nlm.nih.gov/pubmed/23887721
http://dx.doi.org/10.3390/molecules18088799
work_keys_str_mv AT palangsuntikulrungtiva holographicquantitativestructureactivityrelationshipsoftryptaminederivativesatnmda5ht1aand5ht2areceptors
AT bernerheinz holographicquantitativestructureactivityrelationshipsoftryptaminederivativesatnmda5ht1aand5ht2areceptors
AT bergermichaell holographicquantitativestructureactivityrelationshipsoftryptaminederivativesatnmda5ht1aand5ht2areceptors
AT wolschannpeter holographicquantitativestructureactivityrelationshipsoftryptaminederivativesatnmda5ht1aand5ht2areceptors